Parkinson’s disease is the second most frequent neurodegenerative disorder of ageing after Alzheimer’s disease.

Parkinson’s disease is characterized by 4 cardinal motor symptoms: tremor at rest; rigidity; bradykinesia; and postural instability. This progressive disorder is also associated with cognitive, behavioural, and autonomic impairments causing increased disability and contributing to a loss of independence.

Related content

Brain-first vs Body-first Parkinson’s Disease play_circle Video play_circle
Brain-first vs Body-first Parkinson’s Disease

Professor Dr. Per Borghammer unpacks the brain-first vs body-first model of Parkinson’s disease, exploring distinct pathways of progression from the gut or nose and their potential to drive personalized medicine and innovative treatments.

16.12.2024 Parkinson’s Disease
Dopamine in Parkinson’s Disease and Schizophrenia play_circle Video play_circle
Dopamine in Parkinson’s Disease and Schizophrenia

Professors Shen-Yang Lim and Christoph Correll explore dopamine’s role in Parkinson’s disease and schizophrenia, discussing treatment evolution, side effects, and parallels between the disorders. Access more resources at Neurotorium.org.

04.12.2024 Parkinson’s Disease
image Image
Parkinson’s Disease and Braak stages

The Braak staging scheme is a valuable model for conceptualizing PD progression and categorizes PD into stages of neuropathological changes.

11.04.2024 Parkinson’s Disease